Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma

Clinical trial NCT04375527 · TERMINATED

Trial details

NCT number: NCT04375527
Sponsor: Jonsson Comprehensive Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Clinical Stage III Cutaneous Melanoma AJCC V8 Clinical Stage IV Cutaneous Melanoma AJCC V8 Locally Advanced Cutaneous Melanoma Metastatic Cutaneous Melanoma Pathologic Stage III Cutaneous Melanoma AJCC V8 Pathologic Stage IIIA Cutaneous Melanoma AJCC V8 Pathologic Stage IIIB Cutaneous Melanoma AJCC V8 Pathologic Stage IIIC Cutaneous Melanoma AJCC V8 Pathologic Stage IIID Cutaneous Melanoma AJCC V8 Pathologic Stage IV Cutaneous Melanoma AJCC V8 Unresectable Cutaneous Melanoma

Start date: 2020-12-03
Primary completion: 2024-11-22
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.